CURRICULUM VITAE Gerald Louis Andriole, Jr., M.D. Address ...

More documents

Recommendations

Info

130. Oh, J. and Andriole, G.L.: Carcinoma of the Penis: Epidemiology: Incidence, Risk Factors, and Clinical Presentation. UpToDate May, 2003. 131. Andriole, G.L.: Editorial Comment: Prospective Trials Needed. Infections in Urology, 16(2):35, 2003. 132. Emberton M, Andriole, G.L., de la Rosette J., Djavan B. Hoefner ,K., Vela Navarrete, R., Nordling J., Roehrborn, C., Schulman, C., Teillac, P., Tubaro, A. and Nickel J.C.: BPH: A Progressive Disease of the Aging Male. Urology 61(2):267-273, 2003. 133. Lowe, F.C., McConnell, J.D., Hudson, P.B., Romas, N.A., Boake, R., Lieber, M., Elhilali, M., Geller, J., Imperto-McGinely, J., Andriole, G.L., et al: Long-Term 6 Year Experience with Finasteride in Patients with Benign Prostatic Hyperplasia. Urology 61(4):791-796, 2003. 134. Landman, J., Venkatesh, R., Lee, D., Vanlangendonck, R., Morrissey, K., Andriole, G.L., Clayman, R.V. and Sundaram, C.P.: Renal Hypothermia Achieved by Retrograde Endoscopic Cold Saline Perfusion: Technique and Initial Clinical Application. Urology 61(5):1023-1025, 2003. 135. Bhayani SB, Clayman RV, Sundaram CP, Landman J, Andriole G, Figenshau RS, Bullock A, Brandes S, Shalhav A, McDougall E, Kibel AS. Surgical treatment of renal neoplasia: evolving toward a laparoscopic standard of care. Urology. 2003;62(5):821-826. 136. O’Leary, M., Roehrborn, C., Andriole, G.L., Nickel, J.C., Boyle, P., Hoefner, K.: Improvements in Benign Prostatic Hyperplasia-Specific Quality of Life with Dutasteride, the Novel Dual 5α-Reductase Inhibitor. British Journal of Urology 92(3):262-266, 2003. 137. McConnell, J.D., Roehrborn, C.G., Bautista, O.M., Andriole, G.L., Dixon, C.M., Kusek, J.W., et al for the Medical Therapy of Prostatic Symptoms (MTOPS) Research Group: The Long-Term Effects of Doxazosin, Finasteride and the Combination on the Clinical Progression of Benign Prostatic Hyperplasia. NEJM 349(25):2385-2396, 2003. 138. Andriole, G.L.: Dutasteride: A Viewpoint by Gerald L. Andriole. Drugs Aging 29(12):918, 2003 (Editorial Comment). 139. Andriole, G.L., Roehrborn, C., Schulman, C., Slawin, K.M., Somerville, M. and Rittmaster, R.S.: Effect of Dutasteride on the Detection of Prostate Cancer in Men with Benign Prostatic Hyperplasia. Urology 64:537-543, 2004. 140. Anast J.W., Andriole, G.L., Bismar, T.A., Yan, Y., and Humphrey, P.A.: Relating Biopsy and Clinical Variables to Radical Prostatectomy Findings: Can Insignificant and Advanced Prostate Cancer be Predicted in a Screening Population? Urology 64(3):544-550, 2004. 141. Landman J, Venkatesh R, Vanlangendonck R, Andriole GL. Application of a fixed retractor system to facilitate laparoscopic radical prostatectomy. Journal of Urology. 2004;171(2 Pt 1):783-785. 142. Kang, D., Andriole, G.L., van de Vooren R.C., Crawford, E.D., Chia, D., Urban, D.A., Reding, D., Huang, W.Y., and Hayes, R.B.: Risk Behaviors and Benign Prostatic Hyperplasia. BJU International 93:1241-1245, 2004. 143. Andriole, G.L., Humphrey, P., Ray, P., Gleave, M.E., Trachtenberg, J., Thomas, L.N., Lazier, C.B. and Rittmaster, R.S.: Effect of the Dual 5α-Reductase Inhibitor Dutasteride on Markers of Tumor Regression in Prostate Cancer. J Urology 172(3):915-919, 2004. 30
144. Andriole, G.L., Bostwick, D., Brawley, O., Gomella, L., Marberger, M., Tindall, Breed, S., Somerville, M. and Rittmaster, R., for the REDUCE Study Group. Chemoprevention of Prostate Cancer in High Risk Men: Rationale and Design of the REDUCE Trial. J Urology 172(4):1314-1317, 2004. 145. Andriole, G.L., Bruchovsky, N., Chung, L., Matsumoto, A., Rittmaster, R., Roehrborn, C., Russell, D., and Tindall, D.: Dihydrotestosterone (DHT) and the Prostate: The Scientific Rationale for 5α-Reductase Inhibitors in the Treatment of Benign Prostatic Hyperplasia. J Urology 172(4):1399-1403, 2004. 146. Andriole, G.L., Reding, D., Hayes, R.B., Prorok, P.C., Gohagan, J.K., on behalf of the PLCO Steering Committee. The Prostate, Lung, Colon, and Ovarian (PLCO) Cancer Screening Trial: Status and Promise. Urol Onc 22:358-361, 2004. 147. Pinsky, P.F., Andriole, G.L., Kramer, B., Hayes, R., Prorok, P. and Gohagan, J for the Prostate. Lung, Colorectal and Ovarian Project Team: Prostate Biopsy Following a Positive Screen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. J Urology 173(3):746-751, 2005. 148. Iczkowski, K.A., Qiu, J., Qian, J., Somerville, M.C., Rittmaster, R.S., Andriole, G.L., and Bostwick, D.G.: The Dual 5-Alpha-Reductase Inhibitor Dutasteride Induces Atrophic Changes and Decreases Relative Cancer Volume in the Human Prostate. J. Urology 65(1):76-82, 2005. 149. Andriole, G.L., Levin, D.L., Crawford, E.D., Gelmann, E.P., Pinsky, P.F., Chia, D., Kramer, B.S., Reding, D., Church, T.R., Grubb, R.L., Izmirlian, G., Ragard, L.R., Clapp, J.D., Prorok, P.C., and Gohagan, J. K. for the PLCO Project Team: Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the Initial Screening Round of a Randomized Trial. JNCI 97(6):433-438, 2005. 150. Reisinger, K., Tran, V., Figenshau, R.S., Andriole, G.L., Landman, J.: Single-setting bilateral laparoscopic renal surgery: assessment of single-stage procedure. Urology 65(5):892-897, 2005. 151. Andriole, G.L.: Prostate Specific Antigen Based Prostate Cancer Screening: Accumulating Evidence of Efficacy but Persistent Uncertainty. Editorial Comment J Urology 174(2):413-414, 2005. 152. Andriole, G.L., Bostwick, D., Civantos, F, Epstein, J., Lucia, M.S., McDonnell, J., and Roehrborn, C.G.: The Effects of 5α-Reductase Inhibitors on the Natural History, Detection and Grading of Prostate Cancer: Current State of Knowledge. J Urology 174(6):2098-2104, 2005. 153. Bhayani, S.B. and Andriole, G.L.: Pure Laparoscopic Radical Heminephrectomy and Partial Isthmusectomy for Renal Cell Carcinoma in a Horseshoe Kidney: Case Report and Technical Considerations. Urology 66(4):880, 2005. 154. Bhayani, S.B. and Andriole, G.L.: Three Dimensional (3D) Vision: Does It Improve Laparoscopic Skills? An Assessment of 3D Head-Mounted Visualization System. Rev Urol 7(4):211-214, 2005. 155. Kraft P, Pharoah P, Chanock SJ, Albanes D, Kolonel LN, Hayes RB, Altshuler D, Andriole G.L., Berg C, Boeing H, Burtt NP, Bueno-de-Mesquita B, Calle EE, Cann H, Canzian F, Chen YC, Crawford DE, Dunning AM, Feigelson HS, Freedman ML, Gaziano JM, Giovannucci E, Gonzalez CA, Haiman CA, Hallmans G, Henderson BE, Hirschhorn JN, Hunter DJ, Kaaks R, Key T, Marchand LL, Ma J, Overvad K, Palli D, Pike MC, Riboli E, Rodriguez C, Setiawan WV, Stampfer MJ, Stram DO, Thomas G, Thun MJ, Travis R, Trichopoulou A, Virtamo J, Wacholder S.: Genetic Variation in the HSD17B1 Gene and Risk of Prostate Cancer. PLoS Genet. 2005 Nov 25;1(5):e68. 31
Page 1 and 2: CURRICULUM VITAE Gerald Louis Andri
Page 3 and 4: Chairman, Steering Committee, REDUC
Page 5 and 6: Period: 2002-2009 Grant Title: Comp
Page 7 and 8: Grant Title: A Double-Blind, Random
Page 9 and 10: implant) in Community-Based Patient
Page 11 and 12: BIBLIOGRAPHY: I. ABSTRACTS 1. Andri
Page 13 and 14: 27. Andriole, G.L., Coplen, D.E., a
Page 15 and 16: 52. Andriole, G.L., Rao, G.S., Kawa
Page 17 and 18: 76. Yan, Y., Andriole, G.L., Diaz,
Page 19 and 20: 99. Albala, D.M., Andriole, G.L., D
Page 21 and 22: 123. Grubb RL III, Black A, Church
Page 23 and 24: 28. Clayman, R.V., McClennan, B.W.,
Page 25 and 26: 60. Keetch, D.W., Andriole, G.L., C
Page 27 and 28: 90. Monk, T.G., Goodnough, L.T., Br
Page 29: Thermotherapy (P-TUMT) for the Trea
Page 33 and 34: 170. Marks, L.S., Roehrborn, C.G. a
Page 35 and 36: D.S., Chanock, S.J., Thun, M.J. and
Page 37 and 38: 14. Andriole, G.L.: Tumor markers i

CURRICULUM VITAE Gerald Louis Andriole, Jr., M.D. Address ...

Create successful ePaper yourself

Delete template?

Save as template?